We are international
Donate
TEXT SIZE   
   back

The Role Of Osteoclast Differentiation Factor TRANCE in Myeloma-Associated Bone Destruction
By Roger Pearse, MD, Ph.D, Memorial Sloan Kettering Cancer Ctr.
Roger Pearse, MD, Ph.D, Memorial Sloan Kettering Cancer Center
10.01.00

Be the first to comment

 related articles